$325K NIH Phase I Grant: Advancing Urinary Catheter Technology with AvantGuard
AvantGuard has been awarded a $325K NIH Phase I Grant for non-coating antimicrobial, anti-host deposition, anti-inflammatory urinary...
top of page
AvantGuard News
Search
May 18, 2023
AvantGuard’s CEO, Ted Eveleth, Recognized As Most Influential Chemical Manufacturing CEO 2023 – USA
Working Smart and Working Hard AvantGuardTM is creating innovative solutions that manage surfaces and provide long-term protection...
May 11, 2023
AvantGuard Secures $2.85 Million in Oversubscribed Seed Round Funding to Accelerate Research and Dev
NEW YORK, May 11, 2023 /PRNewswire/ -- AvantGuard, a fast-growing company in the antimicrobial industry, announced today the successful...
May 10, 2023
AvantGuard Receives $1M from USDA to Demonstrate Antimicrobial Benefits of AvantGuard247™
AvantGuard, Inc. is pleased to announce a $1 million Phase III award from the United States Department of Agriculture (USDA) to...
May 3, 2023
AvantGuard Wins Frost & Sullivan's North American Technology Innovation Leadership Award
SAN ANTONIO, TX. – May 2, 2023 – Frost & Sullivan recently assessed the North American residual antimicrobials industry and, based on its...
Apr 18, 2023
AvantGuard Receives $1.7M NIH Grant for AvantGuard247™
AvantGuard, Inc. is pleased to announce a $1.7 million Phase II SBIR award from the National Institutes of Health (NIH) to continue...
Apr 1, 2023
The 4 Easiest Ways to Catch Norovirus, and How to Avoid Them
Are you concerned about Norovirus (commonly known as the stomach bug) and its potential impact on your health? Look no further! Below,...
Mar 30, 2023
The Role Of Environment In Infection Transmission
Are you aware of the surprising role that environmental factors play in infection transmission? We invite you to read AvantGuard's latest...
Mar 27, 2023
AvantGuard Unveils New Brand Identity Focusing On Innovative Technologies For a Safer World
ITHACA, N.Y., March 23, 2023 /PRNewswire/ -- AvantGuard, announced today the unveiling of its new brand identity as a transformative...
Aug 13, 2022
Halomine, Inc. Awarded $150K SBIR Phase I from USDA
USDA grant furthers the development of HaloAdd™, our novel thermoplastic additive, to prevent pathogen cross-contamination and biofilms...
Feb 23, 2022
Halomine Inc. ranked among the top 100 companies in the SOSV Human Health 100 showcase list
(Ithaca, NY) — Halomine™, Inc., a pioneer in advanced technology for managing surfaces and providing long-term protection against...
Jan 18, 2022
Halomine CEO Ted Eveleth presented at the ISSA Show North America in Las Vegas Nevada
In November 2021, Halomine CEO Ted Eveleth presented at the ISSA Show North America in Las Vegas Nevada. The ISSA show is the premier...
Oct 5, 2021
Halomine Inc. Awarded $1M Funding From National Science Foundation (NSF) to Help Product Development
Award funds the continued development of Halomine’s flagship product, HaloFilm™, for providing prolonged residual antimicrobial efficacy...
Sep 30, 2021
Halomine Inc. To Receive Funding and R&D Support from The Cornell Center for Material Research
(Ithaca, NY) — Halomine™, Inc., a pioneer in advanced technology for managing surfaces and providing long term protection against...
Jul 28, 2021
Halomine's CEO to present about Residual Antimicrobial Products at ISSA Show North America 2021
Halomine's CEO Ted Eveleth will present at the ISSA Show North America, Las Vegas in November 2021. The presentation, “Residual...
bottom of page